C. Robalo Cordeiro (Coimbra, Portugal), C. Albera (Turin, Italy)
Overexpression of matrix metalloproteinase-7 (MMP-7) in bronchoalveolar lavage fluid (BALF) of IPF and lung cancer patients
K. Samara, I. Giannarakis, I. Papanikoalou, I. Lambiri, N. Siafakas, K. Antoniou (Heraklion, Greece)
|   |
Expression profiling of Th17 cell activators revealed elevation of STAT-3 in progressing sarcoidosis
R. Fillerova, E. Kriegova, T. Tomankova, F. Mrazek, M. Zurkova, V. Kolek, M. Petrek (Olomouc, Czech Republic)
| |
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
R. Borie, C. Quesnel, S. Phin, M. P. Debray, J. Marchal-Somme, K. Tiev, P. Soler, M. Dehoux, B. Crestani (Paris, France)
| |
Characterization of myofibroblasts cultured from small volumes of diagnostic bronchoalveolar lavage fluid samples
R. Kaarteenaho, H. Karvonen, T. Harju, R. Sormunen, E. Lappi-Blanco, M. Keinänen, H. Merikallio, S. Lehtonen (Oulu, Finland)
| |
Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group
P. Kopinski, A. Dyczek, G. Przybylski, B. Balicka-Slusarczyk, A. Jarzemska, T. Wandtke, E. Pólgesek, M. Igielska (Bydgoszcz, Kraków, Poland)
| |
Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)
A. Dyczek, J. Szczeklik, B. Balicka-Slusarczyk, J. Chorostowska, A. Szpechcinski, E. Pólgesek, M. Jankowski, P. Kopinski (Kracow, Warsaw, Bydgoszcz, Poland)
| |
Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage
S. Willems, J. Somers, S. E. Verleden, G. M. Verleden, J. Yserbyt, C. Dooms, B. Vanaudenaerde, W. Wuyts (Leuven, Belgium)
| |
Diagnostic value of bronchoalveolar lavage and lymphocyte transformation test in drug-induced lung disease
Y. Kimizuka, S. Tasaka, W. Yamasawa, M. Ishii, H. Kamata, H. Fujiwara, Y. Funatsu, H. Namkoong, N. Hasegawa, M. Murata, K. Asano (Tokyo, Japan)
| |
Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF
C. Vitale, E. Carpentieri, F. Perna, M. Pitassi, A. Molino, A. Stanziola, M. Sofia (Naples, Italy)
| |
Differential cell count in BAL by flow cytometry using CD15 FITC/CD16PE/CD45 PERCP/HLA-DR APC monoclonal antibodies
M. Arias, B. Palomo, J. Belda, L. Tricas, M. P. Paniagua, C. Martinez, M. Gonzalez, A. Quero, P. Casan (Oviedo, Spain)
| |
LSC 2011 Abstract: Bronchoalveolar lavage in radiation pneumonitis after radiotherapy for breast cancer
C. L. Toma, A. Serbescu, M. Alexe, L. Cervis, D. Ionita, M. A. Bogdan (Bucharest, Romania)
| |
Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC)
O. Anhenn, T. Rabis, U. Sommerwerck, G. Weinreich, J. I. Baumbach, I. Kurth, K. Darwiche, L. Freitag, H. Teschler, U. Costabel (Essen, Saarbrücken, Germany)
| |
Phospho-ERM localization in UIP specimens: An immunohistochemystry approach
S. Inghilleri, G. M. Stella, M. Zorzetto, I. Campo, P. Morbini, T. Oggionni, M. Luisetti (Pavia, Italy)
| |
Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease
T. Samukawa, T. Hamada, G. Tsukuya, H. Inoue (Kagoshima, Japan)
| |
Extracellular matrix profile of lung in idiopathic pulmonary fibrosis
S. Estany, V. Vicens, R. Llatjós, R. Penín, I. Escobar, A. Xaubet, F. Manresa, J. Dorca, M. Molina-Molina (L‘Hospitalet de Llobregat, Barcelona, Spain)
| |
Elevation of serum tumor markers in patients with interstitial lung disease
J. Liu, H. Dai, L. Liang, L. Peng, J. Jiang (Beijing, China)
| |
Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF
F. Drakopanagiotakis, A. Xyfteri, E. Tsiambas, G. Vilaras, A. Karameris, C. Tsakanika, V. Polychronopoulos, D. Bouros (Athens, Alexandroupoli, Greece)
| |
Reliability of ATS/ERS criteria for the diagnosis of idiopathic pulmonary fibrosis
S. Ohshimo, F. Bonella, K. Tanigawa, N. Kohno, J. Guzman, U. Costabel (Essen, Bochum, Germany; Hiroshima, Japan)
| |